Complicated Catheter-Associated Urinary Tract Infections Due to Escherichia coli and Proteus mirabilis
暂无分享,去创建一个
H. Mobley | M. Shirtliff | D. Stickler | D. J. Stickler | S. M. Jacobsen | H. L. T. Mobley | M. E. Shirtliff | S. Jacobsen | Harry L. T. Mobley | Mark E. Shirtliff
[1] I. Orskov,et al. Serology, chemistry, and genetics of O and K antigens of Escherichia coli. , 1977, Bacteriological reviews.
[2] A. Siitonen,et al. Molecular epidemiology of 3 putative virulence genes for Escherichia coli urinary tract infection-usp, iha, and iroN(E. coli). , 2002, The Journal of infectious diseases.
[3] R. Selvarangan,et al. Decay-Accelerating Factor and Cytoskeleton Redistribution Pattern in HeLa Cells Infected with RecombinantEscherichia coli Strains Expressing Dr Family of Adhesins , 1999, Infection and Immunity.
[4] R. Welch,et al. Cytotoxic activity of the Proteus hemolysin HpmA , 1990, Infection and immunity.
[5] G. Ulett,et al. The role of F9 fimbriae of uropathogenic Escherichia coli in biofilm formation. , 2007, Microbiology.
[6] R. Russell,et al. Construction of an MR/P fimbrial mutant of Proteus mirabilis: role in virulence in a mouse model of ascending urinary tract infection , 1994, Infection and immunity.
[7] D. Stickler,et al. Complications of urinary tract infections associated with devices used for long-term bladder management. , 1994, The Journal of hospital infection.
[8] G. Ducel. [Nosocomial infections in the intensive care unit]. , 1987, Schweizerische medizinische Wochenschrift.
[9] B. H. Şen,et al. Ultrastructural stages of biofilm development of Escherichia coli on urethral catheters and effects of antibiotics on biofilm formation. , 2006, Urology.
[10] E. Vinogradov,et al. The structure of the carbohydrate backbone of the core-lipid A region of the lipopolysaccharide from Proteus vulgaris serotype O25. , 2000, Carbohydrate research.
[11] R. Munasinghe,et al. Appropriateness of Use of Indwelling Urinary Catheters in Patients Admitted to the Medical Service , 2001, Infection Control & Hospital Epidemiology.
[12] M. Footer,et al. Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[13] S. Hultgren,et al. Binding of Pili from UropathogenicEscherichia coli to Membranes Secreted by Human Colonocytes and Enterocytes , 1999, Infection and Immunity.
[14] H. Mobley,et al. Construction of a urease-negative mutant of Proteus mirabilis: analysis of virulence in a mouse model of ascending urinary tract infection , 1990, Infection and immunity.
[15] M. Kerr,et al. A proteolytic enzyme secreted by Proteus mirabilis degrades immunoglobulins of the immunoglobulin A1 (IgA1), IgA2, and IgG isotypes , 1990, Infection and immunity.
[16] A. Schmidtchen,et al. Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL‐37 , 2002, Molecular microbiology.
[17] B. Harrison,et al. The binding of Proteus mirabilis nonagglutinating fimbriae to ganglio-series asialoglycolipids and lactosyl ceramide. , 2000, Canadian journal of microbiology.
[18] J. Nataro,et al. Characterization of the AfaD‐like family of invasins encoded by pathogenic Escherichia coli associated with intestinal and extra‐intestinal infections , 2000, FEBS letters.
[19] F. Orskov. Virulence factors of the bacterial cell surface. , 1978, The Journal of infectious diseases.
[20] G. Le Negrate,et al. Escherichia coli cytotoxic necrotizing factor‐1 (CNF‐1) increases the adherence to epithelia and the oxidative burst of human polymorphonuclear leukocytes but decreases bacteria phagocytosis , 2000, Journal of leukocyte biology.
[21] D. Musher,et al. Progression from asymptomatic to symptomatic urinary tract infection in patients with SCI: a preliminary study. , 1993, The Journal of the American Paraplegia Society.
[22] E. Weinberg. Iron withholding: a defense against infection and neoplasia. , 1984, Physiological reviews.
[23] H. Mobley,et al. The IrgA Homologue Adhesin Iha Is an Escherichia coli Virulence Factor in Murine Urinary Tract Infection , 2005, Infection and Immunity.
[24] M. Perry,et al. The structure of the polysaccharide produced by Proteus vulgaris (ATCC 49990). , 1992, Carbohydrate research.
[25] R. C. Stanley,et al. Nosocomial infections in U.S. hospitals, 1975-1976: estimated frequency by selected characteristics of patients. , 1981, The American journal of medicine.
[26] T. Elliott,et al. The pathogenesis of urinary tract infections associated with Escherichia coli, Staphylococcus saprophyticus and S. epidermidis. , 1990, Journal of medical microbiology.
[27] S. Langermann,et al. Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. , 1997, Science.
[28] W. Stamm,et al. Bacterial adherence to bladder uroepithelial cells in catheter-associated urinary tract infection. , 1986, The New England journal of medicine.
[29] P. Taylor,et al. A nosocomial outbreak of infections due to multiply resistant Proteus mirabilis: role of intestinal colonization as a major reservoir. , 1979, The Journal of infectious diseases.
[30] S. Opal,et al. Aerobactin and alpha-hemolysin as virulence determinants in Escherichia coli isolated from human blood, urine, and stool. , 1990, The Journal of infectious diseases.
[31] Y. Knirel,et al. Structural and immunochemical studies on the O-specific polysaccharide of Proteus penneri strain 15. , 1997, Archivum immunologiae et therapiae experimentalis.
[32] L.,et al. The cleavage of immunoglobulin G in vitro and in vivo by a proteinase secreted by the urinary tract pathogen Proteus mirabilis , 2022 .
[33] A. Schaeffer,et al. Relationship of type 1 pilus expression in Escherichia coli to ascending urinary tract infections in mice , 1987, Infection and immunity.
[34] Hui Zhao,et al. Visualization of Proteus mirabilis within the Matrix of Urease-Induced Bladder Stones during Experimental Urinary Tract Infection , 2002, Infection and Immunity.
[35] C. Brinton. The structure, function, synthesis and genetic control of bacterial pili and a molecular model for DNA and RNA transport in gram negative bacteria. , 1965, Transactions of the New York Academy of Sciences.
[36] M. Fitzgerald,et al. A Simplified Method for the Quantitative Bacterial Culture of Urine , 1960, Journal of clinical pathology.
[37] F. Daschner. Nosocomial infections in intensive care units , 1990, Intensive Care Medicine.
[38] R Möllby,et al. Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli. , 2000, The Journal of infectious diseases.
[39] D. Stickler,et al. Bacterial biofilms and the encrustation of urethral catheters , 1996 .
[40] R. Kolter,et al. Biofilm formation as a developmental process. , 2001, Methods in Enzymology.
[41] G. Bitton,et al. Adsorption of microorganisms to surfaces. , 1980 .
[42] D. Rasko,et al. Repression of bacterial motility by a novel fimbrial gene product , 2001, The EMBO journal.
[43] G. Fraser,et al. Swarming-coupled expression of the Proteus mirabilis hpmBA haemolysin operon. , 2002, Microbiology.
[44] F. Albright,et al. Dissolution of Phosphatic Urinary Calculi by the Retrograde Introduction of a Citrate Solution Containing Magnesium , 1943 .
[45] I S Roberts,et al. Structure, assembly and regulation of expression of capsules in Escherichia coli , 1999, Molecular microbiology.
[46] E. Vinogradov,et al. Structural analysis of the core region of lipopolysaccharides from Proteus mirabilis serotypes O6, O48 and O57. , 2000, European journal of biochemistry.
[47] E. Evans. Indwelling catheter care: dispelling the misconceptions. , 1999, Geriatric nursing.
[48] C. Winters,et al. Blockage of urethral catheters by bacterial biofilms. , 1993, The Journal of infection.
[49] H. Mobley,et al. Proteus mirabilis urease: genetic organization, regulation, and expression of structural genes , 1988, Journal of bacteriology.
[50] J. Kur,et al. Molecular Aspects of Biogenesis of Escherichia coli Dr Fimbriae: Characterization of DraB-DraE Complexes , 2005, Infection and Immunity.
[51] V. Thomas,et al. Identification of UreR binding sites in the Enterobacteriaceae plasmid‐encoded and Proteus mirabilis urease gene operons , 1999, Molecular microbiology.
[53] B. Trautner,et al. Prevention of catheter-associated urinary tract infection , 2005, Current opinion in infectious diseases.
[54] Sarah Cope,et al. Using silver to reduce catheter-associated urinary tract infections. , 2005, Nursing standard (Royal College of Nursing (Great Britain) : 1987).
[55] T. Hooton,et al. Management of urinary tract infections in adults. , 1993, The New England journal of medicine.
[56] R. Spencer,et al. Evaluation of six screening methods for detecting significant bacteriuria. , 1988, Journal of clinical pathology.
[57] M. Donnenberg,et al. Internalization of Escherichia coli by human renal epithelial cells is associated with tyrosine phosphorylation of specific host cell proteins , 1997, Infection and immunity.
[58] P. Dasgupta,et al. Urinary tract infections: new insights into a common problem , 2005, Postgraduate Medical Journal.
[59] P. Griffiths,et al. Preventing blockage of long-term indwelling catheters in adults: are citric acid solutions effective? , 2003, British journal of community nursing.
[60] H. Lai,et al. Cell differentiation of Proteus mirabilis is initiated by glutamine, a specific chemoattractant for swarming cells , 1993, Molecular microbiology.
[61] J. Elmore,et al. Urological Survey: Abstracts: Urinary Tract InfectionThe Efficacy of Silver Alloy-Coated Urinary Catheters in Preventing Urinary Tract Infection: A Meta-Analysis , 1999 .
[62] R. Belas,et al. Genetic analysis of Proteus mirabilis mutants defective in swarmer cell elongation , 1995, Journal of bacteriology.
[63] H. Mobley,et al. Internalization of Escherichia coli into human renal tubular epithelial cells. , 1988, The Journal of infectious diseases.
[64] P. Tambyah,et al. Engineering out the risk for infection with urinary catheters. , 2001, Emerging infectious diseases.
[65] S. Payne,et al. Iron and virulence in the family Enterobacteriaceae. , 1988, Critical reviews in microbiology.
[66] R. Hausinger,et al. Proteus mirabilis urease. Partial purification and inhibition by boric acid and boronic acids. , 1988, The Biochemical journal.
[67] J. R. Johnson,et al. Molecular Epidemiological and Phylogenetic Associations of Two Novel Putative Virulence Genes, iha and iroNE. coli, among Escherichia coli Isolates from Patients with Urosepsis , 2000, Infection and Immunity.
[68] S. Falkow,et al. Construction and expression of recombinant plasmids encoding type 1 or D-mannose-resistant pili from a urinary tract infection Escherichia coli isolate , 1981, Infection and immunity.
[69] Stefan Wuertz,et al. High Rates of Conjugation in Bacterial Biofilms as Determined by Quantitative In Situ Analysis , 1999, Applied and Environmental Microbiology.
[70] H. Mobley,et al. Differential regulation of the Proteus mirabilis urease gene cluster by UreR and H-NS. , 2003, Microbiology.
[71] V. Regueiro,et al. Capsule Polysaccharide Mediates Bacterial Resistance to Antimicrobial Peptides , 2004, Infection and Immunity.
[72] A. Jönsson,et al. The importance of osmolality for intermittent catheterization of the urethra , 2000, Spinal Cord.
[73] J. Bullen. The significance of iron in infection. , 1981, Reviews of infectious diseases.
[74] C. Hughes,et al. Production and properties of haemolysins from clinical isolates of the Proteeae. , 1988, Journal of medical microbiology.
[75] H. Mobley,et al. Cytotoxicity of the HpmA hemolysin and urease of Proteus mirabilis and Proteus vulgaris against cultured human renal proximal tubular epithelial cells , 1991, Infection and immunity.
[76] Y. Knirel,et al. Structure of the O-specific polysaccharide of Proteus penneri 62 containing 2-acetamido-3-O-[(S)-1-carboxyethyl]-2-deoxy-D-glucose (N-acetylisomuramic acid). , 1992, Carbohydrate research.
[77] C. B. Smith,et al. Meatal colonization and catheter-associated bacteriuria. , 1980, The New England journal of medicine.
[78] P. Tambyah,et al. A prospective study of pathogenesis of catheter-associated urinary tract infections. , 1999, Mayo Clinic proceedings.
[79] A. Różalski,et al. Hemolytic activity and invasiveness in strains of Proteus penneri , 1987, Journal of clinical microbiology.
[80] R. Suvanasuthi,et al. The Ability of Proteus mirabilis To Sense Surfaces and Regulate Virulence Gene Expression Involves FliL, a Flagellar Basal Body Protein , 2005, Journal of bacteriology.
[81] M. Perry,et al. Capsule structure of Proteus mirabilis (ATCC 49565) , 1992, Journal of bacteriology.
[82] J. R. Johnson,et al. Virulence factors in Escherichia coli urinary tract infection , 1991, Clinical Microbiology Reviews.
[83] K. Kotełko,et al. Proteus mirabilis: taxonomic position, peculiarities of growth, components of the cell envelope. , 1986, Current topics in microbiology and immunology.
[84] D. Musher,et al. Urease. The primary cause of infection-induced urinary stones. , 1976, Investigative urology.
[85] H. Mobley,et al. Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains , 1990, Infection and immunity.
[86] M. Kagayama,et al. An electron microscopic study of the interaction between vesical epitherlium and E. Coli. , 1979, Investigative urology.
[87] H. Mobley,et al. Proteus mirabilis MR/P fimbrial operon: genetic organization, nucleotide sequence, and conditions for expression , 1994, Journal of bacteriology.
[88] M. Mulvey,et al. Adhesion and entry of uropathogenic Escherichia coli , 2002, Cellular microbiology.
[89] Kshitij D Modi,et al. Noninvasive Biophotonic Imaging for Monitoring of Catheter-Associated Urinary Tract Infections and Therapy in Mice , 2005, Infection and Immunity.
[90] M. Rosenheim. MANDELIC ACID IN THE TREATMENT OF URINARY INFECTIONS , 1935 .
[91] C. Osborne,et al. Infection (urease) stones. , 1987, Mineral and electrolyte metabolism.
[92] R. M. Donlan,et al. Biofilms and device-associated infections. , 2001, Emerging infectious diseases.
[93] B. Saxon,et al. Use of the Bac-T-Screen to predict bacteriuria from urine specimens held at room temperature , 1986, Journal of clinical microbiology.
[94] G. Reid,et al. Effects of ciprofloxacin, norfloxacin, and ofloxacin on in vitro adhesion and survival of Pseudomonas aeruginosa AK1 on urinary catheters , 1994, Antimicrobial Agents and Chemotherapy.
[95] A. Schaeffer. Pilot Trial of Bacterial Interference for Preventing Urinary Tract Infection , 2002 .
[96] J. Burke,et al. Antimicrobial Prophylaxis for Catheter-Associated Bacteriuria , 1977, Antimicrobial Agents and Chemotherapy.
[97] T. Lam,et al. Types of urethral catheters for management of short-term voiding problems in hospitalised adults. , 2008, The Cochrane database of systematic reviews.
[98] P. Rather. Swarmer cell differentiation in Proteus mirabilis. , 2005, Environmental microbiology.
[99] R. Russell,et al. Contribution of Proteus mirabilis urease to persistence, urolithiasis, and acute pyelonephritis in a mouse model of ascending urinary tract infection , 1993, Infection and immunity.
[100] J. Costerton,et al. Introduction to biofilm. , 1999, International journal of antimicrobial agents.
[101] Eshwar Mahenthiralingam,et al. Ultrastructure of Proteus mirabilis Swarmer Cell Rafts and Role of Swarming in Catheter-Associated Urinary Tract Infection , 2004, Infection and Immunity.
[102] W. Donovan,et al. Pilot trial of bacterial interference for preventing urinary tract infection. , 2001, Urology.
[103] R. Hull,et al. Molecular cloning of Proteus mirabilis uroepithelial cell adherence (uca) genes , 1995, Infection and immunity.
[104] J. Brisson,et al. Application of 1D and 2D NMR techniques to the structure elucidation of the O-polysaccharide from Proteus mirabilis O: 57 , 1994, Journal of biomolecular NMR.
[105] V. Thomas,et al. Activation of transcription at divergent urea‐dependent promoters by the urease gene regulator UreR , 1996, Molecular microbiology.
[106] E. Mahenthiralingam,et al. Genotyping demonstrates that the strains of Proteus mirabilis from bladder stones and catheter encrustations of patients undergoing long-term bladder catheterization are identical. , 2004, The Journal of urology.
[107] D. Stickler,et al. Why are Foley catheters so vulnerable to encrustation and blockage by crystalline bacterial biofilm? , 2003, Urological Research.
[108] J. Hebel,et al. Internalization of Escherichia coli into human kidney epithelial cells: comparison of fecal and pyelonephritis-associated strains. , 1994, The Journal of infectious diseases.
[109] H. Mobley,et al. Proteus mirabilis urease: operon fusion and linker insertion analysis of ure gene organization, regulation, and function , 1995, Journal of bacteriology.
[110] A. J. Cox. Comparison of catheter surface morphologies. , 1990, British journal of urology.
[111] William C Maxted,et al. Urinalysis: a comprehensive review. , 2005, American family physician.
[112] Craig A. Umscheid,et al. Guideline for Prevention of Catheter-Associated Urinary Tract Infections 2009 , 2010, Infection Control & Hospital Epidemiology.
[113] Michael P. Sheetz,et al. Pilus retraction powers bacterial twitching motility , 2000, Nature.
[114] H. Lai,et al. Co‐ordinate expression of virulence genes during swarm‐cell differentiation and population migration of Proteus mirabilis , 1992, Molecular microbiology.
[115] S. Hultgren,et al. Role of intestinal surfactant-like particles as a potential reservoir of uropathogenic Escherichia coli. , 2000, Biochimica et biophysica acta.
[116] M. Schembri,et al. FimH‐mediated autoaggregation of Escherichia coli , 2001, Molecular microbiology.
[117] B. Hess,et al. Pathophysiologie, Diagnostik und konservative Therapie bei nicht-kalziumhaltigen Nierensteinen , 2003 .
[118] M. Kerr,et al. A survey of IgA protease production among clinical isolates of Proteeae. , 1988, Journal of medical microbiology.
[119] A. Różalski,et al. Characterization of cell-bound and cell-free hemolytic activity of proteus strains , 1991, European Journal of Epidemiology.
[120] J. Penner,et al. Separate O-grouping schemes for serotyping clinical isolates of Proteus vulgaris and Proteus mirabilis , 1980, Journal of clinical microbiology.
[121] S. Saint. Clinical and economic consequences of nosocomial catheter-related bacteriuria. , 2000, American journal of infection control.
[122] H. Mobley,et al. Proteus mirabilis Genes That Contribute to Pathogenesis of Urinary Tract Infection: Identification of 25 Signature-Tagged Mutants Attenuated at Least 100-Fold , 2004, Infection and Immunity.
[123] C. B. Smith,et al. Factors predisposing to bacteriuria during indwelling urethral catheterization. , 1975, The New England journal of medicine.
[124] A. Hesse,et al. Chemolitholysis and Lithotripsy of Infectious Urinary Stones – An in vitro Study , 2002, Urologia Internationalis.
[125] D. Musher,et al. Role of urease in pyelonephritis resulting from urinary tract infection with Proteus. , 1975, The Journal of infectious diseases.
[126] R. Schwarzhoff,et al. Nature of the swarming phenomenon in Proteus. , 1978, Annual review of microbiology.
[127] H. Mobley,et al. Proteus mirabilis mannose-resistant, Proteus-like fimbriae: MrpG is located at the fimbrial tip and is required for fimbrial assembly , 1997, Infection and immunity.
[128] T. Wilt,et al. Systematic Review: Antimicrobial Urinary Catheters To Prevent Catheter-Associated Urinary Tract Infection in Hospitalized Patients , 2006, Annals of Internal Medicine.
[129] T. Möttönen,et al. P fimbria-specific B cell responses in patients with urinary tract infection. , 2003, The Journal of infectious diseases.
[130] M. Regué,et al. The inner-core lipopolysaccharide biosynthetic waaE gene: function and genetic distribution among some Enterobacteriaceae. , 2002, Microbiology.
[131] S. Hultgren,et al. Bacterial pili: molecular mechanisms of pathogenesis. , 2000, Current opinion in microbiology.
[132] U. Seydel,et al. Lipid-Specific Membrane Activity of Human β-Defensin-3† , 2006 .
[133] B. Jones,et al. Role of swarming in the formation of crystalline Proteus mirabilis biofilms on urinary catheters. , 2005, Journal of medical microbiology.
[134] D. Maskell,et al. Virulence of a Proteus mirabilis ATF isogenic mutant is not impaired in a mouse model of ascending urinary tract infection. , 2000, FEMS immunology and medical microbiology.
[135] W. Anthony,et al. A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. , 1982, The Journal of infectious diseases.
[136] R. Welch. Pore‐forming cytolysins of Gram‐negative bacteria , 1991, Molecular microbiology.
[137] Jona Zumeris,et al. Effective Prevention of Microbial Biofilm Formation on Medical Devices by Low-Energy Surface Acoustic Waves , 2006, Antimicrobial Agents and Chemotherapy.
[138] H. Mobley,et al. Proteus mirabilis amino acid deaminase: cloning, nucleotide sequence, and characterization of aad , 1995, Journal of bacteriology.
[139] B. Trautner,et al. Role of biofilm in catheter-associated urinary tract infection. , 2004, American journal of infection control.
[140] A. Torzewska,et al. Crystallization of urine mineral components may depend on the chemical nature of Proteus endotoxin polysaccharides. , 2003, Journal of medical microbiology.
[141] V. Braun,et al. Pore-forming bacterial protein hemolysins (cytolysins). , 1991, Critical reviews in microbiology.
[142] D. E. Bradley. A function of Pseudomonas aeruginosa PAO polar pili: twitching motility. , 1980, Canadian journal of microbiology.
[143] J. Hacker,et al. Pathogenicity islands and the evolution of microbes. , 2000, Annual review of microbiology.
[144] J. Chawla,et al. Virulence factors in Escherichia coli from urinary tract infections in patients with spinal injuries. , 1992, The Journal of hospital infection.
[145] H. Mobley,et al. Requirement of MrpH for Mannose-ResistantProteus-Like Fimbria-Mediated Hemagglutination byProteus mirabilis , 1999, Infection and Immunity.
[146] M. T. Beck,et al. Down-Regulation of the kps Region 1 Capsular Assembly Operon following Attachment of Escherichia coli Type 1 Fimbriae to d-Mannose Receptors , 2005, Infection and Immunity.
[147] H. Mobley,et al. Urinary tract infections : molecular pathogenesis and clinical management , 1996 .
[148] M. Kerr,et al. The production and activity in vivo of Proteus mirabilis IgA protease in infections of the urinary tract. , 1991, Journal of medical microbiology.
[149] S. Kjelleberg,et al. Do marine natural products interfere with prokaryotic AHL regulatory systems , 1997 .
[150] R. Belas,et al. Sequence and genetic analysis of multiple flagellin-encoding genes from Proteus mirabilis. , 1994, Gene.
[151] T. Russo,et al. IroN Functions as a Siderophore Receptor and Is a Urovirulence Factor in an Extraintestinal Pathogenic Isolate of Escherichia coli , 2002, Infection and Immunity.
[152] İ. Kaleli,et al. Production by Escherichia coli isolates of siderophore and other virulence factors and their pathogenic role in a cutaneous infection model. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[153] C. Bloch,et al. Virulence characteristics of Escherichia coli causing first urinary tract infection predict risk of second infection. , 1995, The Journal of infectious diseases.
[154] D. Classen,et al. A large randomized clinical trial of a silver-impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. , 1995, The American journal of medicine.
[155] H. Mobley,et al. Role of Motility in the Colonization of Uropathogenic Escherichia coli in the Urinary Tract , 2005, Infection and Immunity.
[156] L. Emödy,et al. The role of swarm cell differentiation and multicellular migration in the uropathogenicity of Proteus mirabilis. , 1994, The Journal of infectious diseases.
[157] G. O’Toole,et al. Microbial Biofilms: from Ecology to Molecular Genetics , 2000, Microbiology and Molecular Biology Reviews.
[158] Limin Zheng,et al. Uropathogenic Escherichia coli Triggers Oxygen-Dependent Apoptosis in Human Neutrophils through the Cooperative Effect of Type 1 Fimbriae and Lipopolysaccharide , 2004, Infection and Immunity.
[159] C. Svanborg,et al. Intestinal carriage of P fimbriated Escherichia coli and the susceptibility to urinary tract infection in young children. , 1995, The Journal of infectious diseases.
[160] W. Hörl,et al. Common errors in diagnosis and management of urinary tract infection. II: clinical management. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[161] W. Stamm,et al. Prevention of catheter-associated urinary tract infection with a silver oxide-coated urinary catheter: clinical and microbiologic correlates. , 1990, The Journal of infectious diseases.
[162] A. Camilli,et al. Detection and analysis of gene expression during infection by in vivo expression technology. , 2000, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[163] Harry L. T. Mobley,et al. Sat, the Secreted Autotransporter Toxin of Uropathogenic Escherichia coli, Is a Vacuolating Cytotoxin for Bladder and Kidney Epithelial Cells , 2002, Infection and Immunity.
[164] Carlene A. Muto,et al. A randomized crossover study of silver-coated urinary catheters in hospitalized patients. , 2000, Archives of internal medicine.
[165] P. Urvil,et al. Dr Operon-Associated Invasiveness ofEscherichia coli from Pregnant Patients with Pyelonephritis , 2001, Infection and Immunity.
[166] K. Hantke,et al. Functions of the siderophore esterases IroD and IroE in iron-salmochelin utilization. , 2005, Microbiology.
[167] R. Crow,et al. Bacteriuria during indwelling urethral catheterization. , 1988, The Journal of hospital infection.
[168] Hongjian Liu,et al. Identification of Proteus mirabilisMutants with Increased Sensitivity to Antimicrobial Peptides , 2001, Antimicrobial Agents and Chemotherapy.
[169] A. N. Kondakova,et al. Structure of the neutral O-polysaccharide and biological activities of the lipopolysaccharide of Proteus mirabilis O20. , 2004, Carbohydrate research.
[170] H. Mobley,et al. Identification of MrpI as the sole recombinase that regulates the phase variation of MR/P fimbria, a bladder colonization factor of uropathogenic Proteus mirabilis , 2002, Molecular microbiology.
[171] P. Thibault,et al. Galectin-3-mediated adherence of Proteus mirabilis to Madin-Darby canine kidney cells. , 2001, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[172] E. Vinogradov,et al. The structure and serological specificity of Proteus mirabilis O43 O antigen. , 1995, European journal of biochemistry.
[173] P. Scardino,et al. Efficacy of antimicrobial-impregnated bladder catheters in reducing catheter-associated bacteriuria: a prospective, randomized, multicenter clinical trial. , 1999, Urology.
[174] H. Mobley,et al. Proteus mirabilis flagella and MR/P fimbriae: isolation, purification, N-terminal analysis, and serum antibody response following experimental urinary tract infection , 1991, Infection and immunity.
[175] F. Nowrouzian,et al. Enhanced persistence in the colonic microbiota of Escherichia coli strains belonging to phylogenetic group B2: role of virulence factors and adherence to colonic cells. , 2006, Microbes and infection.
[176] A. N. Kondakova,et al. Structure of the O-polysaccharide of a serologically separate strain of Proteus mirabilis, TG 332, from a new proposed Proteus serogroup O50. , 2003, Carbohydrate research.
[177] Scott J. Hultgren,et al. Functional Genomic Studies of Uropathogenic Escherichia coli and Host Urothelial Cells when Intracellular Bacterial Communities Are Assembled* , 2007, Journal of Biological Chemistry.
[178] H. Mobley,et al. Proteus mirabilis fimbriae: N-terminal amino acid sequence of a major fimbrial subunit and nucleotide sequences of the genes from two strains , 1993, Infection and immunity.
[179] Robert B. Simmons,et al. Effects of silver on adherence of bacteria to urinary catheters: In vitro studies , 2004, Current Microbiology.
[180] J. Gates,et al. Urinary tract infection in surgical patients. , 2003, American journal of surgery.
[181] J. Nickel,et al. The ecology and pathogenicity of urease-producing bacteria in the urinary tract. , 1988, Critical reviews in microbiology.
[182] O. Gofrit,et al. Complete staghorn calculi: random prospective comparison between extracorporeal shock wave lithotripsy monotherapy and combined with percutaneous nephrostolithotomy. , 1997, The Journal of urology.
[183] W. Donovan,et al. Urinary tract infection prophylaxis using Escherichia coli 83972 in spinal cord injured patients. , 2000, The Journal of urology.
[184] R. Suvanasuthi,et al. Proteus mirabilis ZapA Metalloprotease Degrades a Broad Spectrum of Substrates, Including Antimicrobial Peptides , 2004, Infection and Immunity.
[185] J. Lawrence,et al. Proteus mirabilis biofilm protection against struvite crystal dissolution and its implications in struvite urolithiasis. , 1991, The Journal of urology.
[186] E. Vinogradov,et al. The structure of the O-specific polysaccharide chain of Proteus penneri strain 16 lipopolysaccharide. , 1991, European journal of biochemistry.
[187] A. Jansen,et al. Visualization of Proteus mirabilis Morphotypes in the Urinary Tract: the Elongated Swarmer Cell Is Rarely Observed in Ascending Urinary Tract Infection , 2003, Infection and Immunity.
[188] R. Kolter,et al. Genetic analysis of Escherichia coli biofilm formation: roles of flagella, motility, chemotaxis and type I pili , 1998, Molecular microbiology.
[189] Structure of a 2-aminoethyl phosphate-containing O-specific polysaccharide of Proteus penneri 63 from a new serogroup O68. , 2000, European journal of biochemistry.
[190] James R. Anderson,et al. Effect of silver-coated urinary catheters: efficacy, cost-effectiveness, and antimicrobial resistance. , 2004, American journal of infection control.
[191] W. Stamm,et al. Urinary tract infections in women: diagnosis and treatment. , 1989, Annals of internal medicine.
[192] S. Hultgren,et al. Bacterial Invasion Augments Epithelial Cytokine Responses to Escherichia coli Through a Lipopolysaccharide-Dependent Mechanism1 , 2001, The Journal of Immunology.
[193] R. Powell,et al. Crystallization and preliminary X-ray diffraction analysis of a biologically active fragment of CD55. , 1999, Acta crystallographica. Section D, Biological crystallography.
[194] R. Hausinger,et al. Copyright � 1995, American Society for Microbiology Molecular Biology of Microbial Ureases , 1995 .
[195] T. Kirikae,et al. Bacterial endotoxin: molecular relationships of structure to activity and function , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[196] H. Mobley,et al. Proteus mirabilis fimbriae: identification, isolation, and characterization of a new ambient-temperature fimbria , 1994, Infection and immunity.
[197] R. Belas. Expression of multiple flagellin-encoding genes of Proteus mirabilis , 1994, Journal of bacteriology.
[198] D. Cravens,et al. Urinary catheter management. , 2000, American family physician.
[199] J. Gunn. Bacterial modification of LPS and resistance to antimicrobial peptides , 2001, Journal of endotoxin research.
[200] J. Lingeman,et al. Evolution of the technique of combination therapy for staghorn calculi: a decreasing role for extracorporeal shock wave lithotripsy. , 1992, The Journal of urology.
[201] J. Pinkner,et al. Type 1 pilus‐mediated bacterial invasion of bladder epithelial cells , 2000, The EMBO journal.
[202] J. Roberts,et al. Bacterial adherence to urethral catheters. , 1990, The Journal of urology.
[203] E. Vinogradov,et al. Structural studies on the fucosamine-containing O-specific polysaccharide of Proteus vulgaris O19. , 1989, European journal of biochemistry.
[204] C. Bryan,et al. Hospital-acquired bacteremic urinary tract infection: epidemiology and outcome. , 1984, The Journal of urology.
[205] I. Henderson,et al. PicU, a second serine protease autotransporter of uropathogenic Escherichia coli. , 2004, FEMS microbiology letters.
[206] R. Podschun,et al. Klebsiella spp. as Nosocomial Pathogens: Epidemiology, Taxonomy, Typing Methods, and Pathogenicity Factors , 1998, Clinical Microbiology Reviews.
[207] W. Rabsch,et al. Further differentiation of Enterobacteriaceae by means of siderophore-pattern analysis. , 1988, Zentralblatt fur Bakteriologie, Mikrobiologie, und Hygiene. Series A, Medical microbiology, infectious diseases, virology, parasitology.
[208] R. Carlson,et al. The structure of the colony migration factor from pathogenic Proteus mirabilis. A capsular polysaccharide that facilitates swarming. , 1999, The Journal of biological chemistry.
[209] B. Trautner,et al. Colicins prevent colonization of urinary catheters. , 2005, The Journal of antimicrobial chemotherapy.
[210] R. Cook,et al. Identification and characterization of a uroepithelial cell adhesin from a uropathogenic isolate of Proteus mirabilis , 1986, Infection and Immunity.
[211] W. Goebel,et al. Contribution of cloned virulence factors from uropathogenic Escherichia coli strains to nephropathogenicity in an experimental rat pyelonephritis model , 1986, Infection and immunity.
[212] H. Mayer,et al. Properties of a deep Proteus R mutant isolated from clinical material , 1991, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[213] F. Ørskov. Virulence Factors of the Bacterial Cell Surface , 1978 .
[214] P. Lambert,et al. The role of the O and K antigens in determining the resistance of Klebsiella aerogenes to serum killing and phagocytosis. , 1983, Journal of general microbiology.
[215] J. Hacker,et al. Receptor Structure for F1C Fimbriae of Uropathogenic Escherichia coli , 2000, Infection and Immunity.
[216] R. Belas,et al. Detection and mutation of a luxS-encoded autoinducer in Proteus mirabilis. , 2002, Microbiology.
[217] C. Fuqua,et al. Biofilms on Indwelling Urethral Catheters Produce Quorum-Sensing Signal Molecules In Situ and In Vitro , 1998, Applied and Environmental Microbiology.
[218] R. Marcus. Narrow-bore suprapubic bladder drainage in Uganda. , 1967, Lancet.
[219] H. Mobley,et al. H-NS Is a Repressor of the Proteus mirabilis Urease Transcriptional Activator GeneureR , 2000, Journal of bacteriology.
[220] S. Langermann,et al. Vaccination utilizing the FimCH complex as a strategy to prevent Escherichia coli urinary tract infections. , 2001, The Journal of infectious diseases.
[221] T. Kirikae,et al. Biological activities of lipopolysaccharides of Proteus spp. and their interactions with polymyxin B and an 18-kDa cationic antimicrobial protein (CAP18)-derived peptide. , 2000, Journal of medical microbiology.
[222] R. Belas,et al. Construction of a flagellum-negative mutant of Proteus mirabilis: effect on internalization by human renal epithelial cells and virulence in a mouse model of ascending urinary tract infection , 1996, Infection and immunity.
[223] P. Stanley,et al. Acylation of Escherichia coli Hemolysin: A Unique Protein Lipidation Mechanism Underlying Toxin Function , 1998, Microbiology and Molecular Biology Reviews.
[224] R. Russell,et al. Comparison of Escherichia coli strains recovered from human cystitis and pyelonephritis infections in transurethrally challenged mice. , 1999, Infection and immunity.
[225] P Jain,et al. Overuse of the indwelling urinary tract catheter in hospitalized medical patients. , 1995, Archives of internal medicine.
[226] H. Mobley,et al. Cloning of urease gene sequences from Providencia stuartii , 1986, Infection and immunity.
[227] C. Hennekens,et al. Prevention of catheter-associated urinary tract infection. An additional measure. , 1972, JAMA.
[228] E. Vinogradov,et al. Structure of the 0-specific polysaccharide of Proteus mirabilis S 1959. , 1987, Archivum immunologiae et therapiae experimentalis.
[229] D. Hukins,et al. Feasability of Preventing Encrustation of Urinary Catheters , 1995 .
[230] D. Eto,et al. Covert Operations of Uropathogenic Escherichia coli within the Urinary Tract , 2005, Traffic.
[231] M. Kerr,et al. The cleavage of immunoglobulin G in vitro and in vivo by a proteinase secreted by the urinary tract pathogen Proteus mirabilis. , 1993, Journal of medical microbiology.
[232] S. Hultgren,et al. Toll-like receptor 4 on stromal and hematopoietic cells mediates innate resistance to uropathogenic Escherichia coli , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[233] H. Mobley,et al. Genetic organization and complete sequence of the Proteus mirabilis pmf fimbrial operon. , 1994, Gene.
[234] J. Tenney,et al. MR/K hemagglutination of Providencia stuartii correlates with adherence to catheters and with persistence in catheter-associated bacteriuria. , 1988, The Journal of infectious diseases.
[235] M. Kerr,et al. Proteus mirabilis strains of diverse type have IgA protease activity. , 1987, Journal of medical microbiology.
[236] B. J. Hinnebusch,et al. Depolymerization of β-1,6-N-Acetyl-d-Glucosamine Disrupts the Integrity of Diverse Bacterial Biofilms , 2005, Journal of bacteriology.
[237] V. Koronakis,et al. Identification of the promotors directing in vivo expression of hemolysin genes in Proteus vulgaris and Escherichia coli , 1988, Molecular and General Genetics MGG.
[238] C. Wandersman,et al. Cloning, nucleotide sequence and characterization of the gene encoding the Erwinia chrysanthemi B374 PrtA metalloprotease: a third metalloprotease secreted via a C-terminal secretion signal , 1992, Molecular and General Genetics MGG.
[239] R. Adegbola,et al. Haemagglutinins and fimbriae of Morganella, Proteus and Providencia. , 1982, Journal of medical microbiology.
[240] B. Harrison,et al. The expression of nonagglutinating fimbriae and its role in Proteus mirabilis adherence to epithelial cells. , 1997, Canadian journal of microbiology.
[241] V. Koronakis,et al. The secreted hemolysins of Proteus mirabilis, Proteus vulgaris, and Morganella morganii are genetically related to each other and to the alpha-hemolysin of Escherichia coli , 1987, Journal of Bacteriology.
[242] P. Barrow,et al. Enterobacteriaceae , 2008, Poultry Diseases.
[243] C. Kunin. Detection, Prevention, and Management of Urinary Tract Infections , 1979 .
[244] W. Dunne,et al. Bacterial Adhesion: Seen Any Good Biofilms Lately? , 2002, Clinical Microbiology Reviews.
[245] S. Gorman,et al. Biofilm and biofilm-related encrustation of urinary tract devices. , 1999, Methods in Enzymology.
[246] J. Priestley,et al. Branched renal calculi. , 1949, The Journal of urology.
[247] R. Welch. Identification of two different hemolysin determinants in uropathogenic Proteus isolates , 1987, Infection and immunity.
[248] T. Habuchi,et al. Distribution and genetic association of putative uropathogenic virulence factors iroN, iha, kpsMT, ompT and usp in Escherichia coli isolated from urinary tract infections in Japan. , 2003, The Journal of urology.
[249] K. K. Lai,et al. Use of silver-hydrogel urinary catheters on the incidence of catheter-associated urinary tract infections in hospitalized patients. , 2002, American journal of infection control.
[250] H. Mobley,et al. Internalization of Proteus mirabilis by human renal epithelial cells , 1994, Infection and immunity.
[251] S. Hultgren,et al. CD14- and Toll-Like Receptor-Dependent Activation of Bladder Epithelial Cells by Lipopolysaccharide and Type 1 Piliated Escherichia coli , 2003, Infection and Immunity.
[252] E. Greenberg,et al. A component of innate immunity prevents bacterial biofilm development , 2002, Nature.
[253] A. Diokno,et al. Patient satisfaction and the LoFric catheter for clean intermittent catheterization. , 1995, The Journal of urology.
[254] B. Trautner,et al. Escherichia coli 83972 inhibits catheter adherence by a broad spectrum of uropathogens. , 2003, Urology.
[255] H. Mobley,et al. Transcriptome of Uropathogenic Escherichia coli during Urinary Tract Infection , 2004, Infection and Immunity.
[256] D. MacLaren,et al. Vero cell invasiveness of Proteus mirabilis , 1984, Infection and immunity.
[257] M. Waters,et al. A Sensor To Detect the Early Stages in the Development of Crystalline Proteus mirabilis Biofilm on Indwelling Bladder Catheters , 2006, Journal of Clinical Microbiology.
[258] H. Mobley,et al. Use of Translational Fusion of the MrpH Fimbrial Adhesin-Binding Domain with the Cholera Toxin A2 Domain, Coexpressed with the Cholera Toxin B Subunit, as an Intranasal Vaccine To Prevent Experimental Urinary Tract Infection by Proteus mirabilis , 2004, Infection and Immunity.
[259] W. Thomas,et al. The synthesis and function of the Escherichia coli hemolysin and related RTX exotoxins. , 1992, FEMS microbiology immunology.
[260] J W Warren,et al. Fever, bacteremia, and death as complications of bacteriuria in women with long-term urethral catheters. , 1987, The Journal of infectious diseases.
[261] L. Truong,et al. Development of experimental model of chronic pyelonephritis with Escherichia coli O75:K5:H-bearing Dr fimbriae: mutation in the dra region prevented tubulointerstitial nephritis. , 1997, The Journal of clinical investigation.
[262] J. Kur,et al. A surface-exposed DraD protein of uropathogenic Escherichia coli bearing Dr fimbriae may be expressed and secreted independently from DraC usher and DraE adhesin. , 2005, Microbiology.
[263] J. Lingeman,et al. Nephrolithiasis Clinical Guidelines Panel summary report on the management of staghorn calculi. The American Urological Association Nephrolithiasis Clinical Guidelines Panel. , 1994, The Journal of urology.
[264] Bogdan Nowicki,et al. Urinary tract infection in pregnant women: Old dogmas and current concepts regarding pathogenesis , 2002, Current infectious disease reports.
[265] D. Beauchemin,et al. Unique ability of the Proteus mirabilis capsule to enhance mineral growth in infectious urinary calculi , 1994, Infection and immunity.
[266] H. Lode,et al. Pharmacokinetics of ciprofloxacin after oral and parenteral administration , 1985, Antimicrobial Agents and Chemotherapy.
[267] W. Gaastra,et al. Nucleotide sequences of two fimbrial major subunit genes, pmpA and ucaA, from canine-uropathogenic Proteus mirabilis strains. , 1995, Microbiology.
[268] G. Leverson,et al. Phase 2 clinical trial of a vaginal mucosal vaccine for urinary tract infections. , 2003, The Journal of urology.
[269] R. Belas,et al. Transposon mutagenesis in Proteus mirabilis , 1991, Journal of bacteriology.
[270] P. Zunino,et al. Evaluation of Proteus mirabilis structural fimbrial proteins as antigens against urinary tract infections. , 2003, FEMS immunology and medical microbiology.
[271] J. Costerton,et al. Pseudomonas aeruginosa biofilm as a diffusion barrier to piperacillin , 1992, Antimicrobial Agents and Chemotherapy.
[272] A. Hartstein,et al. Nosocomial Urinary Tract Infection: A Prospective Evaluation of 108 Catheterized Patients , 1981, Infection Control.
[273] A. Plaut. The IgA1 proteases of pathogenic bacteria. , 1983, Annual review of microbiology.
[274] A. Siitonen,et al. Predominance of class II papG allele of Escherichia coli in pyelonephritis in infants with normal urinary tract anatomy. , 2000, The Journal of infectious diseases.
[275] F. Keeley,et al. Evidence for the use of silver-alloy-coated urethral catheters. , 2005, The Journal of hospital infection.
[276] F. Falkiner. The insertion and management of indwelling urethral catheters--minimizing the risk of infection. , 1993, The Journal of hospital infection.
[277] L. Nicolle. A Practical Guide to Antimicrobial Management of Complicated Urinary Tract Infection , 2001, Drugs & aging.
[278] M. Moeschberger,et al. The association between the use of urinary catheters and morbidity and mortality among elderly patients in nursing homes. , 1992, American journal of epidemiology.
[279] L. Sampath,et al. Evaluation of the Antimicrobial Efficacy of Urinary Catheters Impregnated With Antiseptics in an In Vitro Urinary Tract Model , 2003, Infection Control & Hospital Epidemiology.
[280] S. Hultgren,et al. Requirement of Rho‐family GTPases in the invasion of Type 1‐piliated uropathogenic Escherichia coli , 2002, Cellular microbiology.
[281] Structure of the O-specific polysaccharide of Proteus penneri 71 and classification of cross-reactive P. penneri strains to a new proposed serogroup O64. , 2000, European journal of biochemistry.
[282] D. Musher,et al. Do condom catheter collecting systems cause urinary tract infection? , 1979, JAMA.
[283] R. McLean,et al. Expression of a nonagglutinating fimbria by Proteus mirabilis , 1995, Infection and immunity.
[284] A. Jansen,et al. Mannose-Resistant Proteus-Like Fimbriae Are Produced by Most Proteus mirabilis Strains Infecting the Urinary Tract, Dictate the In Vivo Localization of Bacteria, and Contribute to Biofilm Formation , 2004, Infection and Immunity.
[285] P. Zunino,et al. Flagellate and non-flagellate Proteus mirabilis in the development of experimental urinary tract infection. , 1994, Microbial pathogenesis.
[286] K. Hantke,et al. The detection of salmochelin and yersiniabactin in uropathogenic Escherichia coli strains by a novel hydrolysis-fluorescence-detection (HFD) method. , 2005, International journal of medical microbiology : IJMM.
[287] H. Mobley,et al. Coordinate Expression of Fimbriae in Uropathogenic Escherichia coli , 2005, Infection and Immunity.
[288] H. C. van der Mei,et al. Uropathogenic Escherichia coli adhere to urinary catheters without using fimbriae. , 1996, FEMS immunology and medical microbiology.
[289] D. Koukalová,et al. [Development of a vaccine for treatment of urinary tract infections]. , 1999, Bratislavske lekarske listy.
[290] D. MacLaren,et al. Uropathogenic properties of Proteus mirabilis and Proteus vulgaris. , 1985, Journal of medical microbiology.
[291] F. Maynard,et al. A prospective randomized trial of the LoFric hydrophilic coated catheter versus conventional plastic catheter for clean intermittent catheterization. , 2003, The Journal of urology.
[292] Betsy Foxman,et al. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. , 2002, The American journal of medicine.
[293] J. R. Johnson,et al. Identification of a New Iron-Regulated Virulence Gene,ireA, in an Extraintestinal Pathogenic Isolate ofEscherichia coli , 2001, Infection and Immunity.
[294] E. Vinogradov,et al. Full structure of the O-specific polysaccharide of Proteus mirabilis O24 containing 3,4-O-[(S)-1-carboxyethylidene]-D-galactose. , 2000, Carbohydrate research.
[295] A. D. Russell,et al. A strategy for the control of catheter blockage by crystalline Proteus mirabilis biofilm using the antibacterial agent triclosan. , 2005, European urology.
[296] G. Waksman,et al. Structural Basis of the Interaction of the Pyelonephritic E. coli Adhesin to Its Human Kidney Receptor , 2001, Cell.
[297] F. A. Troy,et al. Polysialylation: from bacteria to brains. , 1992, Glycobiology.
[298] G. Hirschfield,et al. Comparison of the Lumac and Monolight systems for detection of bacteriuria by bioluminescence , 1984, Journal of Clinical Microbiology.
[299] D. Stickler,et al. Which indwelling urethral catheters resist encrustation by Proteus mirabilis biofilms? , 1997, British journal of urology.
[300] W. L. Chapman,et al. Nutritional iron status and susceptibility to Proteus mirabilis pyelonephritis in the rat. , 1982, Canadian journal of microbiology.
[301] L. Clapham,et al. The influence of bacteria on struvite crystal habit and its importance in urinary stone formation , 1990 .
[302] J. Thornby,et al. Pre-inoculation of urinary catheters with Escherichia coli 83972 inhibits catheter colonization by Enterococcus faecalis. , 2002, The Journal of urology.
[303] T. Scott. THE BACTERIOLOGY OF URINARY INFECTIONS IN PARAPLEGIA , 1960, Journal of clinical pathology.
[304] D. Stickler,et al. Modulation of crystalline Proteus mirabilis biofilm development on urinary catheters. , 2006, Journal of medical microbiology.
[305] J M Hughes,et al. CDC definitions for nosocomial infections, 1988. , 1988, American journal of infection control.
[306] H. Mobley,et al. MrpB Functions as the Terminator for Assembly of Proteus mirabilis Mannose-Resistant Proteus-Like Fimbriae , 1998, Infection and Immunity.
[307] M. Bailey,et al. Requirement for FlhA in flagella assembly and swarm‐cell differentiation by Proteus mirabilis , 1995, Molecular microbiology.
[308] H. Mobley,et al. Urease activity of Proteus penneri , 1987, Journal of clinical microbiology.
[309] S J Stahl,et al. Extracellular slime associated with Proteus mirabilis during swarming. , 1983, Journal of bacteriology.
[310] A. O’Brien,et al. Cytotoxic Necrotizing Factor Type 1 of Uropathogenic Escherichia coli Kills Cultured Human Uroepithelial 5637 Cells by an Apoptotic Mechanism , 2000, Infection and Immunity.
[311] H. Hahn,et al. The type-4 pilus is the major virulence-associated adhesin of Pseudomonas aeruginosa--a review. , 1997, Gene.
[312] P. Tambyah,et al. Catheter-associated urinary tract infection is rarely symptomatic: a prospective study of 1,497 catheterized patients. , 2000, Archives of internal medicine.
[313] S. E. Jorgensen,et al. Studies on the origin of the alpha-haemolysin produced by Escherichia coli. , 1976, Journal of medical microbiology.
[314] L. Nicolle,et al. Management of Complicated Urinary Tract Infection in Older Patients , 1996, Journal of the American Geriatrics Society.
[315] Michael J. Long,et al. An electrified catheter to resist encrustation by Proteus mirabilis biofilm. , 2005, The Journal of urology.
[316] A. Hodari,et al. Trocar suprapubic cystostomy for postoperative bladder drainage in the female. , 1966, American journal of obstetrics and gynecology.
[317] G. Donelli,et al. Cytotoxic necrotizing factor production by hemolytic strains of Escherichia coli causing extraintestinal infections , 1987, Journal of clinical microbiology.
[318] D. Watson,et al. Proteus mirabilis ambient-temperature fimbriae: cloning and nucleotide sequence of the aft gene cluster , 1996, Infection and immunity.
[319] N. Yakandawala,et al. Antibiofilm Activity of GlmU Enzyme Inhibitors against Catheter-Associated Uropathogens , 2006, Antimicrobial Agents and Chemotherapy.
[320] Adrian Russell,et al. Control of encrustation and blockage of Foley catheters , 2003, The Lancet.
[321] H. Holthöfer,et al. Tissue-binding affinity of Proteus mirabilis fimbriae in the human urinary tract , 1990, Infection and immunity.
[322] R. Selvarangan,et al. Family of Escherichia coli Dr adhesins: decay-accelerating factor receptor recognition and invasiveness. , 2001, The Journal of infectious diseases.
[323] R. Belas,et al. Swarming and pathogenicity of Proteus mirabilis in the urinary tract. , 1995, Trends in microbiology.
[324] M. Viñas,et al. New fimbrial adhesins of Serratia marcescens isolated from urinary tract infections: description and properties. , 1997, The Journal of urology.
[325] S. Hultgren,et al. Intracellular bacterial communities of uropathogenic Escherichia coli in urinary tract pathogenesis. , 2004, Trends in microbiology.
[326] W. Feast,et al. Observations on the adherence of Proteus mirabilis onto polymer surfaces , 2006, Journal of applied microbiology.
[327] S. Hultgren,et al. Intracellular Bacterial Biofilm-Like Pods in Urinary Tract Infections , 2003, Science.
[328] M. Schembri,et al. Biofilm Formation in a Hydrodynamic Environment by Novel FimH Variants and Ramifications for Virulence , 2001, Infection and Immunity.
[329] A. Conway,et al. Activity of a nitrofurazone matrix urinary catheter against catheter-associated uropathogens , 1993, Antimicrobial Agents and Chemotherapy.
[330] C. Kunin. Can we build a better urinary catheter? , 1988, The New England journal of medicine.
[331] J W Warren,et al. Catheter-associated urinary tract infections. , 2012, Critical care nurse.
[332] P. Tambyah,et al. The relationship between pyuria and infection in patients with indwelling urinary catheters: a prospective study of 761 patients. , 2000, Archives of internal medicine.
[333] M. Siroky. Pathogenesis of bacteriuria and infection in the spinal cord injured patient. , 2002, The American journal of medicine.
[334] S. Arend,et al. Is there evidence for recommending silver-coated urinary catheters in guidelines? , 2002, The Journal of hospital infection.
[335] S. Tasker,et al. Bergey’s Manual of Systematic Bacteriology , 2010 .
[336] V. Gant,et al. Interactions of lactoferricin-derived peptides with LPS and antimicrobial activity. , 2004, FEMS microbiology letters.
[337] C. Murphy,et al. Genomic rearrangements in the flagellin genes of Proteus mirabilis , 1999, Molecular microbiology.
[338] P. Larsson. 6 Serology of Proteus mirabilis and Proteus vulgaris , 1984 .
[339] P. Stewart. New ways to stop biofilm infections , 2003, The Lancet.
[340] P. Stączek,et al. Cell-free and cell-bound hemolytic activities of Proteus penneri determined by different Hly determinants. , 1991, Canadian journal of microbiology.
[341] D. Alling,et al. Prevention of catheter-associated urinary tract infections. Efficacy of daily meatal care regimens. , 1981, The American journal of medicine.
[342] S. Walz,et al. Multiple proteins encoded within the urease gene complex of Proteus mirabilis , 1988, Journal of bacteriology.
[343] S. Hultgren,et al. Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[344] G. Bartsch,et al. An Escherichia coli-based oral vaccine against urinary tract infections potently activates human dendritic cells. , 2002, Urology.
[345] P. Freestone,et al. Stimulation of Staphylococcus epidermidis growth and biofilm formation by catecholamine inotropes , 2003, The Lancet.
[346] S. Abraham,et al. Type 1 fimbriated Escherichia coli-mast cell interactions in cystitis. , 2001, The Journal of infectious diseases.
[347] R. Glockshuber,et al. Uroplakin Ia is the urothelial receptor for uropathogenic Escherichia coli: evidence from in vitro FimH binding. , 2001, Journal of cell science.
[348] R. Welch,et al. The HpmA hemolysin is more common than HlyA among Proteus isolates , 1990, Infection and immunity.
[349] D. Griffith,et al. Treatment options in struvite stones. , 1997, The Urologic clinics of North America.
[350] S. Saint,et al. Are physicians aware of which of their patients have indwelling urinary catheters? , 2000, The American journal of medicine.
[351] D. Hooper,et al. Fluoroquinolone antimicrobial agents. , 1991, Clinical microbiology reviews.
[352] H. Mobley,et al. Pathogenesis of Proteus mirabilis urinary tract infection. , 2000, Microbes and infection.
[353] W. Jarvis,et al. Selected Aspects of the Socioeconomic Impact of Nosocomial Infections: Morbidity, Mortality, Cost, and Prevention , 1996, Infection Control & Hospital Epidemiology.
[354] H. Mobley,et al. Identification of Sat, an autotransporter toxin produced by uropathogenic Escherichia coli , 2000, Molecular microbiology.
[355] E. Vinogradov,et al. Structural Study of O-Specific Polysaccharides of Proteus , 1993 .
[356] D. Rasko,et al. Autotransporter Genes pic and tsh Are Associated with Escherichia coli Strains That Cause Acute Pyelonephritis and Are Expressed during Urinary Tract Infection , 2004, Infection and Immunity.
[357] A. Schaeffer,et al. Current concepts in urinary tract infections. , 2004, Minerva urologica e nefrologica = The Italian journal of urology and nephrology.
[358] S. Saint,et al. Biofilms and catheter-associated urinary tract infections. , 2003, Infectious disease clinics of North America.
[359] R. Freter,et al. Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin , 1983, Infection and immunity.
[360] R. Adegbola,et al. Multiple fimbrial haemagglutinins inSerratia species , 2005, Medical Microbiology and Immunology.
[361] V. Holers,et al. Epithelial secretion of C3 promotes colonization of the upper urinary tract by Escherichia coli , 2001, Nature Medicine.
[362] H. Mobley,et al. Proteus mirabilis MR/P fimbriae: molecular cloning, expression, and nucleotide sequence of the major fimbrial subunit gene , 1993, Journal of bacteriology.
[363] J. Oliver,et al. Role of iron in the pathogenesis of Vibrio vulnificus infections , 1981, Infection and immunity.
[364] J. Fabry,et al. Randomized multi-centre trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital-acquired urinary tract infections. , 2000, The Journal of hospital infection.
[365] Z. Sidorczyk,et al. Studies on lipopolysaccharides of Proteus vulgaris serogroups. Chemotypes of genus Proteus lipopolysaccharides. , 1975, Bulletin de l'Academie polonaise des sciences. Serie des sciences biologiques.
[366] A. Plaut. Microbial IgA proteases. , 1978, The New England journal of medicine.
[367] D. Newman. Managing indwelling urethral catheters. , 1998, Ostomy/wound management.
[368] Z. Sidorczyk,et al. Potential virulence factors of Proteus bacilli. , 1997, Microbiology and molecular biology reviews : MMBR.
[369] D. Stickler,et al. The migration of Proteus mirabilis and other urinary tract pathogens over Foley catheters , 2002, BJU international.
[370] R. Belas,et al. ZapA, the IgA‐degrading metalloprotease of Proteus mirabilis, is a virulence factor expressed specifically in swarmer cells , 1999, Molecular microbiology.
[371] F. Duong,et al. Sequence of a cluster of genes controlling synthesis and secretion of alkaline protease in Pseudomonas aeruginosa: relationships to other secretory pathways. , 1992, Gene.
[372] A. Iravani. Advances in the understanding and treatment of urinary tract infections in young women. , 1991, Urology.
[373] I. Blomfield,et al. In vivo phase variation of MR/P fimbrial gene expression in Proteus mirabilis infecting the urinary tract , 1997, Molecular microbiology.
[374] A. N. Kondakova,et al. Structure and serological characterization of the O-antigen of Proteus mirabilis O18 with a phosphocholine-containing oligosaccharide phosphate repeating unit. , 2003, Carbohydrate research.
[375] J. Costerton,et al. Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms , 2002, Clinical Microbiology Reviews.
[376] M. Burdick,et al. Neutrophil recruitment and resistance to urinary tract infection. , 1999, The Journal of infectious diseases.
[377] G. Shand,et al. In vivo evidence that bacteria in urinary tract infection grow under iron-restricted conditions , 1985, Infection and immunity.
[378] R. Belas,et al. The Genera Proteus, Providencia, and Morganella , 2006 .
[379] S. Krajden,et al. Proteus penneri and urinary calculi formation , 1984, Journal of clinical microbiology.
[381] J. Mcghee,et al. Difference in susceptibility to gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice , 1984, Infection and immunity.
[382] C. Svanborg,et al. Epithelial cytokine responses and mucosal cytokine networks. , 1995, Trends in microbiology.
[383] G. Wilding,et al. TheSiderophore Receptor IroN of Extraintestinal PathogenicEscherichia coli Is a Potential VaccineCandidate , 2003, Infection and Immunity.
[384] E. Vinogradov,et al. Structure of Proteus mirabilis O27 O-specific polysaccharide containing amino acids and phosphoethanolamine. , 1989, European journal of biochemistry.
[385] B. Yangco,et al. CDC definitions for nosocomial infections. , 1989, American journal of infection control.
[386] H. Mobley,et al. Genetic and biochemical diversity of ureases of Proteus, Providencia, and Morganella species isolated from urinary tract infection , 1987, Infection and immunity.
[387] W. Ko,et al. Decreased predominance of papG class II allele in Escherichia coli strains isolated from adults with acute pyelonephritis and urinary tract abnormalities. , 2001, The Journal of urology.
[388] D. Maskell,et al. Proteus mirabilis fimbriae (PMF) are important for both bladder and kidney colonization in mice. , 2003, Microbiology.
[389] Kelly J. Wright,et al. Development of intracellular bacterial communities of uropathogenic Escherichia coli depends on type 1 pili , 2007, Cellular microbiology.
[390] M. Waters,et al. A clinical assessment of the performance of a sensor to detect crystalline biofilm formation on indwelling bladder catheters , 2006, BJU international.
[391] Kelly J. Wright,et al. Uropathogenic Escherichia coli Flagella Aid in Efficient Urinary Tract Colonization , 2005, Infection and Immunity.
[392] N. Khardori,et al. Modulation of biofilms of Pseudomonas aeruginosa by quinolones , 1995, Antimicrobial agents and chemotherapy.
[393] A. N. Kondakova,et al. Structural and serological studies of the O-antigen of Proteus mirabilis O-9. , 2003, Carbohydrate research.
[394] J. Tenney,et al. Expression of type 1 fimbriae may be required for persistence of Escherichia coli in the catheterized urinary tract , 1987, Journal of clinical microbiology.
[395] D. MacLaren,et al. Investigation of the haemolytic activity of Proteus mirabilis strains , 1983, Antonie van Leeuwenhoek.
[396] S. Hultgren,et al. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. , 1998, Science.
[397] C. Svanborg,et al. Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[398] R. Kolter,et al. Exopolysaccharide Production Is Required for Development of Escherichia coli K-12 Biofilm Architecture , 2000, Journal of bacteriology.
[399] J. Preston,et al. The pgaABCD Locus of Escherichia coli Promotes the Synthesis of a Polysaccharide Adhesin Required for Biofilm Formation , 2004, Journal of bacteriology.
[400] M. Gelman. Antibiotic irrigation and catheter-associated urinary tract infections. , 1980, Nephron.
[401] S. Krajden,et al. Expanded clinical spectrum of infections caused by Proteus penneri , 1987, Journal of clinical microbiology.
[402] D. Stickler,et al. Encrustation of indwelling urethral catheters by Proteus mirabilis biofilms growing in human urine. , 1998, The Journal of hospital infection.
[403] A. Siitonen,et al. Variations in 10 putative uropathogen virulence genes among urinary, faecal and peri-urethral Escherichia coli. , 2002, Journal of medical microbiology.
[404] R. Belas,et al. Molecular analysis of a metalloprotease from Proteus mirabilis , 1995, Journal of bacteriology.
[405] Thomas P. Minka,et al. Gates , 2008, NIPS.
[406] R. Chaitow. Guideline for prevention of catheter-associated urinary tract infections. , 1981, Infection control : IC.
[407] R. Kolter,et al. [2] Biofilm formation as a developmental process , 2001 .
[408] P. Rather,et al. Evidence that putrescine acts as an extracellular signal required for swarming in Proteus mirabilis , 2004, Molecular microbiology.
[409] J. Heesemann,et al. Characterization of an iroBCDEN Gene Cluster on a Transmissible Plasmid of Uropathogenic Escherichia coli: Evidence for Horizontal Transfer of a Chromosomal Virulence Factor , 2003, Infection and Immunity.
[410] C. Tang,et al. Type 1 fimbriae and extracellular polysaccharides are preeminent uropathogenic Escherichia coli virulence determinants in the murine urinary tract , 2002, Molecular microbiology.
[411] M. Meng,et al. Infections and urinary stone disease. , 2003, Current pharmaceutical design.
[412] M. Loeb,et al. Why are antibiotics prescribed for asymptomatic bacteriuria in institutionalized elderly people? A qualitative study of physicians' and nurses' perceptions. , 2000, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[413] S. Clegg,et al. Enterobacterial fimbriae , 1987, Journal of bacteriology.
[414] T. Dawson,et al. 37-kDa Laminin Receptor Precursor Modulates Cytotoxic Necrotizing Factor 1–mediated RhoA Activation and Bacterial Uptake* , 2003, The Journal of Biological Chemistry.
[415] D. Old,et al. The haemagglutinins and fimbriae of Proteus penneri. , 1989, Journal of medical microbiology.
[416] James R. Johnson. Microbial virulence determinants and the pathogenesis of urinary tract infection. , 2003, Infectious disease clinics of North America.
[417] J. Neilands,et al. Molecular mechanism of regulation of siderophore-mediated iron assimilation. , 1987, Microbiological reviews.
[418] A. Schaeffer. Types of urethral catheters for management of short-term voiding problems in hospitalised adults. , 2005, The Journal of urology.
[419] G. Jung,et al. Alpha-keto acids are novel siderophores in the genera Proteus, Providencia, and Morganella and are produced by amino acid deaminases , 1993, Journal of bacteriology.
[420] K. Krogfelt,et al. Capsule and Fimbria Interaction in Klebsiella pneumoniae , 2005, Infection and Immunity.
[421] G. Reid,et al. Can bacterial interference prevent infection? , 2001, Trends in microbiology.
[422] Ankur H. Shah,et al. Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection. , 1997, The Journal of clinical investigation.
[423] Viktoria Hancock,et al. Specific selection for virulent urinary tract infectious Escherichia coli strains during catheter-associated biofilm formation. , 2007, FEMS immunology and medical microbiology.
[424] Public health focus: surveillance, prevention, and control of nosocomial infections. , 1992, MMWR. Morbidity and mortality weekly report.
[425] C. Fiorentini,et al. Escherichia coli Cytotoxic Necrotizing Factor 1 Blocks Cell Cycle G2/M Transition in Uroepithelial Cells , 2006, Infection and Immunity.
[426] M. Kerr,et al. Proteinases of Proteus spp.: purification, properties, and detection in urine of infected patients , 1992, Infection and immunity.
[427] A. O’Brien,et al. Cytotoxic Necrotizing Factor Type 1 Production by Uropathogenic Escherichia coli Modulates Polymorphonuclear Leukocyte Function , 2005, Infection and Immunity.
[428] C. Pederzolli,et al. Permeability Increase Induced by Escherichia coli Hemolysin A in Human Macrophages is Due to the Formation of Ionic Pores: A Patch Clamp Characterization , 1996, The Journal of Membrane Biology.
[429] B. Senior,et al. Rare occurrence of Proteus vulgaris in faeces: a reason for its rare association with urinary tract infections. , 1986, Journal of medical microbiology.
[430] W. Stamm. Catheter-associated urinary tract infections: epidemiology, pathogenesis, and prevention. , 1991, The American journal of medicine.
[431] H. Mobley,et al. Proteus mirabilis urease: transcriptional regulation by UreR , 1993, Journal of bacteriology.
[432] H. Mobley,et al. Proteus mirabilis fimbriae: construction of an isogenic pmfA mutant and analysis of virulence in a CBA mouse model of ascending urinary tract infection , 1994, Infection and immunity.
[433] J. Beizer. Urinary incontinence in women: a review for the pharmacist. , 1996, Journal of the American Pharmaceutical Association.
[434] M. Rohde,et al. The multicellular morphotypes of Salmonella typhimurium and Escherichia coli produce cellulose as the second component of the extracellular matrix , 2001, Molecular microbiology.
[435] P. Larsson,et al. 0 antigen distribution and sensitivity to the bactericidal effect of normal human serum ofProteus strains from clinical specimens , 1977, Medical Microbiology and Immunology.
[436] J. Pinkner,et al. STRUCTURAL BASIS OF THE INTERACTION OF THE PYELONEPHRITIC E. , 2001 .
[437] Scott J. Hultgren,et al. Bacterial Adhesins: Common Themes and Variations in Architecture and Assembly , 1999, Journal of bacteriology.
[438] G. Reid,et al. The effect of protein and urine on uropathogen adhesion to polymer substrata. , 1990, Journal of biomedical materials research.
[439] J. Hacker,et al. Binding of Escherichia coli S fimbriae to human kidney epithelium , 1986, Infection and immunity.
[440] R. Belas,et al. Proteus mirabilis mutants defective in swarmer cell differentiation and multicellular behavior , 1991, Journal of bacteriology.
[441] S. Kadis,et al. Siderophore production by Proteus mirabilis. , 1984, Canadian journal of microbiology.
[442] Y. Knirel,et al. Structural and serological studies on the O-antigen of Proteus mirabilis O14, a new polysaccharide containing 2-[(R)-1-carboxyethylamino]ethyl phosphate. , 1999, European journal of biochemistry.
[443] P Mullany,et al. Transfer of a conjugative transposon, Tn5397 in a model oral biofilm. , 1999, FEMS microbiology letters.
[444] C. Deighton,et al. Anti-Proteus antibodies in rheumatoid arthritis same-sexed sibships. , 1992, British journal of rheumatology.
[445] M. Emberton,et al. Catheter‐associated urinary tract infections: prevalence of uropathogens and pattern of antimicrobial resistance in a UK hospital (1996–2001) , 2003, BJU international.
[446] T. Knoll,et al. [Pathophysiology, diagnosis and conservative therapy of non-calcium kidney calculi]. , 2003, Therapeutische Umschau. Revue therapeutique.
[447] K. Zych,et al. Lipopolysaccharides of Proteus penneri species novum. , 1989, Carbohydrate research.
[448] H. Mobley,et al. Development of an Intranasal Vaccine To Prevent Urinary Tract Infection by Proteus mirabilis , 2004, Infection and Immunity.
[449] R. Selvarangan,et al. Dr fimbriae operon of uropathogenic Escherichia coli mediate microtubule-dependent invasion to the HeLa epithelial cell line. , 1997, The Journal of infectious diseases.
[450] H. Lai,et al. A cell‐surface polysaccharide that facilitates rapid population migration by differentiated swarm cells of Proteus mirabilis , 1995, Molecular microbiology.
[451] M. Priebe,et al. Limited vs full microbiological investigation for the management of symptomatic polymicrobial urinary tract infection in adult spinal cord-injured patients , 1997, Spinal Cord.
[452] A. Ebringer,et al. Rheumatoid arthritis and proteus: a possible aetiological association , 2004, Rheumatology International.
[453] T. Yamamoto,et al. Fimbria‐Mediated Adherence of Serratia marcescens Strain US5 to Human Urinary Bladder Surface , 1985, Microbiology and immunology.
[454] V. Koronakis,et al. Identification of the promoters directing in vivo expression of hemolysin genes in Proteus vulgaris and Escherichia coli. , 1988, Molecular & general genetics : MGG.
[455] Y. Knirel,et al. Structure of the O-polysaccharide and classification of Proteus mirabilis strain G1 in Proteus serogroup O3. , 2002, European journal of biochemistry.
[456] L. A. Fernández,et al. Secretion and assembly of regular surface structures in Gram-negative bacteria. , 2000, FEMS microbiology reviews.
[457] R. Welch,et al. Nucleotide sequencing of the Proteus mirabilis calcium-independent hemolysin genes (hpmA and hpmB) reveals sequence similarity with the Serratia marcescens hemolysin genes (shlA and shlB) , 1990, Journal of bacteriology.